acquisitionNovo Nordisk to acquire Cardior PharmaceuticalsLatest News Novo Nordisk is set to acquire German miRNA blocker specialist Cardior Pharmaceuticals GmbH for up to €1.025bn including milestone payments. Read more 25 March 2024 https://european-biotechnology.com/wp-content/uploads/2024/04/Cardior_43-Edit_copy.png 1536 1920 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-03-25 12:44:432024-06-13 14:03:39Novo Nordisk to acquire Cardior Pharmaceuticals